| DC Field | Value | Language |
|---|
| dc.contributor.author | Slyusarenko, V. S. | - |
| dc.contributor.author | Kovalenko, S. M. | - |
| dc.contributor.author | Chuev, V. P. | - |
| dc.contributor.author | Gureev, V. V. | - |
| dc.contributor.author | Korokin, M. V. | - |
| dc.date.accessioned | 2022-05-11T13:08:40Z | - |
| dc.date.available | 2022-05-11T13:08:40Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Study of analgesic activity and effects of new dipharmacophores - nebracetam and cyclooxygenase-2 inhibitors derivatives on the cognitive abilities of rats / V.S. Slyusarenko [et al.] // Research Results in Pharmacology. - 2021. - Vol.7, №4.-P. 71-79. - Doi: 10.3897/rrpharmacology.7.78463. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46665 | - |
| dc.description.abstract | The aim of the present study was to research the analgesic activity and effect of new dipharmacophore compounds consisting of substances with proven therapeutic activity, namely nebracetam-ibuprofen (NRIP), nebracetam-dexibuprofen (NRDIP), nebracetam-niflumic acid (NRNFA), and nebracetam-mefenamic acid (NRMFA), on the cognitive abilities of rats | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | NSAID | ru |
| dc.subject | nootropic drugs | ru |
| dc.subject | nebracetam | ru |
| dc.subject | COX-2 | ru |
| dc.subject | dipharmacophores | ru |
| dc.subject | analgesic activity | ru |
| dc.subject | cognitive abilities | ru |
| dc.subject | laboratory animals | ru |
| dc.title | Study of analgesic activity and effects of new dipharmacophores - nebracetam and cyclooxygenase-2 inhibitors derivatives on the cognitive abilities of rats | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 7, № 4
|
